Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD.

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • DeFilipp, Z; Purcell, M; Harris, WAC; Chandra, DJ; Gleason, C; Wrammert, J; Sarantopoulos, S; Waller, EK

Published Date

  • April 2016

Published In

Volume / Issue

  • 51 / 4

Start / End Page

  • 607 - 609

PubMed ID

  • 26642338

Electronic International Standard Serial Number (EISSN)

  • 1476-5365

Digital Object Identifier (DOI)

  • 10.1038/bmt.2015.304

Language

  • eng

Conference Location

  • England